These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37786819)

  • 1. Evaluation of Diagnostic Usefulness of CD200 Expression in B-cell Chronic Lymphoproliferative Disorders.
    Purohit A; Satiza M; Somasundaram V; Sharma R; Mishra P; Seth T; Tyagi S; Mahapatra M; Pati HP; Saxena R
    Indian J Hematol Blood Transfus; 2023 Oct; 39(4):684-690. PubMed ID: 37786819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
    Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
    Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotyping of chronic B-cell neoplasms: flow cytometry versus immunohistochemistry.
    Abdel-Ghafar AA; El Din El Telbany MA; Mahmoud HM; El-Sakhawy YN
    Hematol Rep; 2012 Jan; 4(1):e3. PubMed ID: 22567217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry.
    Sandes AF; de Lourdes Chauffaille M; Oliveira CR; Maekawa Y; Tamashiro N; Takao TT; Ritter EC; Rizzatti EG
    Cytometry B Clin Cytom; 2013 Aug; ():. PubMed ID: 24039011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD200 expression in B-cell chronic lymphoproliferative disorders.
    El Desoukey NA; Afify RA; Amin DG; Mohammed RF
    J Investig Med; 2012 Jan; 60(1):56-61. PubMed ID: 22064604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD 200 - A useful marker in chronic B lymphoprolipherative disorders.
    Iova A; Vlădăreanu A; Bumbea H; Begu M; Vasile D; Andruş E
    J Med Life; 2012; 5(Spec Issue):66-70. PubMed ID: 31803290
    [No Abstract]   [Full Text] [Related]  

  • 8. CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry.
    Sandes AF; de Lourdes Chauffaille M; Oliveira CR; Maekawa Y; Tamashiro N; Takao TT; Ritter EC; Rizzatti EG
    Cytometry B Clin Cytom; 2014 Mar; 86(2):98-105. PubMed ID: 24243815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders.
    Mason EF; Pozdnyakova O; Li B; Dudley G; Dorfman DM
    Am J Clin Pathol; 2017 Jul; 148(1):33-41. PubMed ID: 28575142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunophenotype analysis of leukemic mantle cell lymphoma].
    Zhao M; Wu YJ; Fan L; Qiu HR; Yang H; Zhang ZH; Xu W; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):371-6. PubMed ID: 23628035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD200 in differential diagnosis of mature B-cell neoplasm.
    Rahman K; Kumar P; Gupta R; Singh MK; Nityanand S
    Int J Lab Hematol; 2017 Aug; 39(4):384-391. PubMed ID: 28422443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.
    Starostka D; Kriegova E; Kudelka M; Mikula P; Zehnalova S; Radvansky M; Papajik T; Kolacek D; Chasakova K; Talianova H
    Cytometry B Clin Cytom; 2018 Jul; 94(4):576-587. PubMed ID: 29220870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
    El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
    Poongodi R; Varma N; Naseem S; Parveen B; Varma S
    Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting.
    Braylan RC; Orfao A; Borowitz MJ; Davis BH
    Cytometry; 2001 Feb; 46(1):23-7. PubMed ID: 11241503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders.
    Al-Zubaidi HK; Hughes SF
    Br J Biomed Sci; 2023; 80():11573. PubMed ID: 37822353
    [No Abstract]   [Full Text] [Related]  

  • 18. Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.
    Li W; Fang P; Fu G; Liang H; Peng M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1689-1694. PubMed ID: 36748379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Sun Y; Wang SA; Sun T
    Cytometry B Clin Cytom; 2018 Jan; 94(1):148-150. PubMed ID: 28109040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Flow Cytometry Panel for Differential Diagnosis of Mantle Cell Lymphoma from Atypical B-Chronic Lymphocytic Leukaemia.
    Mehrpouri M; Sadat Hosseini M; Jafari L; Mosleh M; Shahabi Satlsar E
    Iran Biomed J; 2023 Jan; 27(1):15-22. PubMed ID: 36624655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.